Studies on biochemical and structural changes in mitochondria in relation to combination treatment with dietary ascorbic acid and Cisplatin in Tumorbearing mice
Nanocarrier mediated Tumor specific Co-delivery of dual-action Cisplatin (IV) prodrug and venetoclax for improved Therapeutic outcomes in triple negative Breast Cancer treatment
